GSK3B and ovarian cancer: In ovarian cancer, Wnt/β-catenin signaling might be activated by increased expression of β-catenin and glycogen synthase kinase 3β (GSK3β), mutations of catenin beta 1 (CTNNB1) gene, and so on [30, 31].